LLS TAP announces five new investments supporting next generation immunotherapies Thumbnail Image Read more about LLS TAP announces five new investments supporting next generation immunotherapies
Collaboration Driving Progress: LLS Forms Alliances with Leading Cancer Institutions and Foundations to Co-Fund nearly $17 million in New Research Grants Thumbnail Image Read more about Collaboration Driving Progress: LLS Forms Alliances with Leading Cancer Institutions and Foundations to Co-Fund nearly $17 million in New Research Grants
LLS, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer Therapies Thumbnail Image Read more about LLS, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer Therapies
Advancing Leading Edge Cancer Research in a $4.5 Million Collaboration Read more about Advancing Leading Edge Cancer Research in a $4.5 Million Collaboration
LLS Releases Results of its Precision Medicine Trial in Deadly Leukemia at ASH Read more about LLS Releases Results of its Precision Medicine Trial in Deadly Leukemia at ASH
New Study Demonstrates Burdensome Cost of Blood Cancer Care Read more about New Study Demonstrates Burdensome Cost of Blood Cancer Care
More Progress on LLS-Supported CAR T-cell Immunotherapy Read more about More Progress on LLS-Supported CAR T-cell Immunotherapy
LLS Applauds Another Advance for Blood Cancer Patients Read more about LLS Applauds Another Advance for Blood Cancer Patients
LLS Announces Expansion of Precision Medicine Approach to Fight Blood Cancer Read more about LLS Announces Expansion of Precision Medicine Approach to Fight Blood Cancer
